| Hybridoma technology a versatile method for isolation of monoclonal antibodies, its applicability across species, limitations, advancement and future perspectives HA Parray, S Shukla, S Samal, T Shrivastava, S Ahmed, C Sharma, ... International immunopharmacology 85, 106639, 2020 | 204 | 2020 |
| Phage display antibody libraries: A robust approach for generation of recombinant human monoclonal antibodies R Kumar, HA Parray, T Shrivastava, S Sinha, K Luthra International journal of biological macromolecules 135, 907-918, 2019 | 99 | 2019 |
| Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B. 1.617. 2) variant surge in India: a test-negative, case-control study and a … R Thiruvengadam, A Awasthi, G Medigeshi, S Bhattacharya, S Mani, ... The Lancet Infectious Diseases 22 (4), 473-482, 2022 | 95 | 2022 |
| Inhalation monoclonal antibody therapy: a new way to treat and manage respiratory infections HA Parray, S Shukla, R Perween, R Khatri, T Shrivastava, V Singh, ... Applied microbiology and biotechnology 105, 6315-6332, 2021 | 62 | 2021 |
| Broadly neutralizing antibodies in HIV-1 treatment and prevention R Kumar, H Qureshi, S Deshpande, J Bhattacharya Therapeutic advances in vaccines and immunotherapy 6 (4), 61-68, 2018 | 62 | 2018 |
| Identification of an anti–SARS–CoV-2 receptor-binding domain–directed human monoclonal antibody from a naïve semisynthetic library HA Parray, AK Chiranjivi, S Asthana, N Yadav, T Shrivastava, S Mani, ... Journal of Biological Chemistry 295 (36), 12814-12821, 2020 | 59 | 2020 |
| Chikungunya and arthritis: An overview R Kumar, S Ahmed, HA Parray, S Das Travel medicine and infectious disease 44, 102168, 2021 | 36 | 2021 |
| Cross-neutralizing anti-HIV-1 human single chain variable fragments (scFvs) against CD4 binding site and N332 glycan identified from a recombinant phage library L Khan, R Kumar, R Thiruvengadam, HA Parray, MA Makhdoomi, ... Scientific reports 7 (1), 45163, 2017 | 35 | 2017 |
| A novel strategy for efficient production of anti-V3 human scFvs against HIV-1 clade C R Kumar, R Andrabi, A Tiwari, SS Prakash, N Wig, D Dutta, A Sankhyan, ... BMC biotechnology 12, 1-15, 2012 | 32 | 2012 |
| Conformational epitope-specific broadly neutralizing plasma antibodies obtained from an HIV-1 clade C-infected elite neutralizer mediate autologous virus escape through … S Patil, R Kumar, S Deshpande, S Samal, T Shrivastava, S Boliar, ... Journal of virology 90 (7), 3446-3457, 2016 | 31 | 2016 |
| Antibody-based therapeutic interventions: possible strategy to counter chikungunya viral infection R Kumar, T Shrivastava, S Samal, S Ahmed, HA Parray Applied microbiology and biotechnology 104, 3209-3228, 2020 | 30 | 2020 |
| HIV-1 clade C escapes broadly neutralizing autologous antibodies with N332 glycan specificity by distinct mechanisms S Deshpande, S Patil, R Kumar, T Hermanus, KG Murugavel, ... Retrovirology 13, 1-9, 2016 | 28 | 2016 |
| The chaperone ERp29 is required for tunneling nanotube formation by stabilizing MSec R Pergu, S Dagar, H Kumar, R Kumar, J Bhattacharya, SVS Mylavarapu Journal of Biological Chemistry 294 (18), 7177-7193, 2019 | 27 | 2019 |
| Cross-neutralization of SARS-CoV-2 by HIV-1 specific broadly neutralizing antibodies and polyclonal plasma N Mishra, S Kumar, S Singh, T Bansal, N Jain, S Saluja, R Kumar, ... PLoS Pathogens 17 (9), e1009958, 2021 | 24 | 2021 |
| Non-neutralizing SARS CoV-2 directed polyclonal antibodies demonstrate cross-reactivity with the HA glycans of influenza virus P Murugavelu, R Perween, T Shrivastava, V Singh, HA Parray, S Singh, ... International Immunopharmacology 99, 108020, 2021 | 17 | 2021 |
| Severe acute respiratory syndrome coronavirus 2 spike protein based novel epitopes induce potent immune responses in vivo and inhibit viral replication in vitro P Vishwakarma, N Yadav, ZA Rizvi, NA Khan, AK Chiranjivi, S Mani, ... Frontiers in immunology 12, 613045, 2021 | 17 | 2021 |
| Isolation and characterization of cross-neutralizing human anti-V3 single-chain variable fragments (scFvs) against HIV-1 from an antigen preselected phage library R Kumar, R Kumari, L Khan, A Sankhyan, HA Parray, A Tiwari, N Wig, ... Applied biochemistry and biotechnology 187, 1011-1027, 2019 | 15 | 2019 |
| CD4-binding site directed cross-neutralizing scFv monoclonals from HIV-1 subtype C infected Indian children S Kumar, R Kumar, L Khan, MA Makhdoomi, R Thiruvengadam, ... Frontiers in Immunology 8, 1568, 2017 | 14 | 2017 |
| Mutations in the reverse transcriptase and protease genes of human immunodeficiency virus-1 from antiretroviral naïve and treated pediatric patients D Bure, MA Makhdoomi, R Lodha, SS Prakash, R Kumar, HA Parray, ... Viruses 7 (2), 590-603, 2015 | 14 | 2015 |
| Cellular immune responses are preserved and may contribute to Chadox1 ChAdOx1 nCoV-19 vaccine effectiveness against infection due to SARS-CoV-2 B· 1· 617· 2 delta variant … R Thiruvengadam, A Awasthi, G Medigeshi, S Bhattacharya, S Mani, ... | 13 | 2021 |
